Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Funding Might Be Stuck At ’06 Levels Through Fall Under Dems’ Plan

This article was originally published in The Gray Sheet

Executive Summary

The incoming Democratic chairs of the House and Senate appropriations committees announced plans last week to scrap the stalled Republican fiscal 2007 spending bills in favor of a year-long continuing resolution that would effectively freeze FDA's budget at fiscal 2006 levels through September

You may also be interested in...



CDRH 2007 budget

FDA's device center and device-related field programs receive $253.7 million as part of a fiscal year 2007 funding measure passed by the House of Representatives Jan. 31. The House voted 286-140 in favor of the $463.5 billion package as a stand-in for nine fiscal 2007 appropriations bills that the previous Congress failed to pass. The CDRH funding represents a 3.2% increase from 2006 and includes $43.7 million in user fees. FDA as a whole is slated to receive $1.96 billion, including all estimated user fees. The Senate is expected to take up the bill by Feb. 15, when the current continuing resolution expires (1"The Gray Sheet" Dec. 18, 2006, p. 10)...

CDRH 2007 budget

FDA's device center and device-related field programs receive $253.7 million as part of a fiscal year 2007 funding measure passed by the House of Representatives Jan. 31. The House voted 286-140 in favor of the $463.5 billion package as a stand-in for nine fiscal 2007 appropriations bills that the previous Congress failed to pass. The CDRH funding represents a 3.2% increase from 2006 and includes $43.7 million in user fees. FDA as a whole is slated to receive $1.96 billion, including all estimated user fees. The Senate is expected to take up the bill by Feb. 15, when the current continuing resolution expires (1"The Gray Sheet" Dec. 18, 2006, p. 10)...

Last-Minute Legislative Package Includes R&D Credit, Medicare Fixes

Congress was poised late last week to pass a legislative package extending a number of tax, trade and health provisions set to expire by year-end, but the bill fails to address some specific device industry priorities

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel